Industry description
The investment seeks to provide long-term growth of capital.
The Portfolio invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities or other securities or instruments with similar economic characteristics, including derivatives related to equity securities. The Manager invests the assets of the Portfolio primarily (under normal circumstances, at least 65% of net assets) in equity securities of issuers in countries that make up the MSCI ACWI ex USA Index, which includes both developed and emerging market countries.
Market Cap
The average market capitalization across the Bernstein International Strat Eqs SCB MF is 55.08B. The market cap for tickers in the group ranges from 3.79B to 88.13B. GSK holds the highest valuation in this group at 88.13B. The lowest valued company is MC at 3.79B.
Volume
The average weekly volume growth across all stocks in the Bernstein International Strat Eqs SCB MF was 23%. For the same stocks of the MF, the average monthly volume growth was 107% and the average quarterly volume growth was 164%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 17
P/E Growth Rating: 62
Price Growth Rating: 50
SMR Rating: 41
Profit Risk Rating: 33
Seasonality Score: 55 (-100 ... +100)